Pembrolizumab Aids Survival With High-Risk Endometrial Cancer
MONDAY, Oct. 21, 2024 (HealthDay News) -- Pembrolizumab plus chemotherapy improves disease-free survival (DFS) in patients with high-risk endometrial cancer after surgery with curative inte...